By Matt Harrington, BCBA · Behaviorist Book Club · Research-backed answers for behavior analysts
The ABA co-treatment model involves a behavior analyst providing services simultaneously or in close coordination with a professional from another discipline, such as a speech-language pathologist or occupational therapist, during the same session. Both professionals work together to address treatment goals that span their respective areas of expertise. The model is designed to produce more integrated, efficient service delivery for clients whose needs cross disciplinary boundaries. Co-treatment differs from consultation, where one professional advises another, and from parallel treatment, where professionals work on similar goals in separate sessions.
The primary ethical concerns center on billing accuracy and defensibility. Code 1.10 of the BACB Ethics Code (2022) requires accurate billing that represents the actual services provided. Concerns include whether both professionals can legitimately bill for the same time period, whether each professional is genuinely providing their unique skilled services throughout the session rather than simply being present, and whether documentation adequately supports the distinct contributions of each professional. Additionally, there is concern about whether co-treatment decisions are driven by clinical need or financial incentive. Each billed unit must be supported by evidence of active, discipline-specific service delivery.
Co-treatment documentation must clearly differentiate the specific contributions of each professional. The behavior analyst's session notes should describe the behavioral strategies implemented, the data collected on behavioral targets, the clinical reasoning applied, and the outcomes observed from a behavioral perspective. The notes should not merely describe shared activities but should demonstrate what the BCBA uniquely contributed that the other professional could not have provided alone. Each professional's documentation should be able to stand independently as evidence of skilled service delivery. Documentation should also note the co-treatment format and the rationale for the collaborative approach for the specific session.
Co-treatment is clinically justified when the client's goals require simultaneous input from both disciplines to be addressed effectively, when integrated delivery produces measurably better outcomes than separate sessions, and when both professionals contribute their unique expertise throughout the session. Co-treatment is less justified when the goals can be addressed equally well through separate sessions, when one professional is primarily observing while the other delivers the primary service, when the arrangement is driven by scheduling convenience or billing optimization rather than clinical need, or when there is no measurable outcome advantage over alternative service delivery models.
Code 1.05 requires behavior analysts to practice within their boundaries of competence, and this obligation does not change during co-treatment. The BCBA should contribute behavioral expertise including reinforcement strategies, prompting procedures, data-based decision-making, and behavioral assessment. They should not provide speech therapy, occupational therapy, or other discipline-specific interventions, even when working alongside those professionals. The collaborative nature of co-treatment means each professional contributes from their area of expertise, and neither professional should cross into the other's scope of practice. Clear role definition before sessions helps maintain these boundaries.
When payers question co-treatment billing, the BCBA should be prepared to provide thorough documentation demonstrating the distinct behavioral services provided during each session, the clinical rationale for the co-treatment format, data showing that both professionals were actively delivering skilled services, evidence that the co-treatment arrangement benefited the client, and the treatment plan goals that required integrated service delivery. Organizations should proactively review payer policies regarding co-treatment before initiating billing and should maintain documentation practices that anticipate potential audits. If a payer's policy prohibits co-treatment billing, the organization must comply regardless of the clinical rationale.
Defensible co-treatment policies should include clear clinical criteria for when co-treatment is appropriate, defined roles and responsibilities for each professional during co-treatment sessions, specific documentation requirements that differentiate each professional's contribution, billing procedures aligned with each payer's requirements, regular quality review processes for co-treatment documentation, outcome monitoring to evaluate co-treatment effectiveness, and training requirements for staff participating in co-treatment. Policies should be reviewed by both clinical leadership and billing compliance experts to ensure they meet ethical, clinical, and regulatory standards. Regular audits should verify that policies are being followed in practice.
Code 2.10 of the BACB Ethics Code (2022) requires behavior analysts to collaborate with professionals who serve their clients when the collaboration benefits the client. This provision supports co-treatment models when they are implemented for genuine clinical benefit. The code encourages behavior analysts to work effectively within interdisciplinary teams, share expertise in accessible language, and incorporate relevant input from other disciplines into treatment planning. However, the code also requires that collaboration occurs within each professional's scope of competence, that billing accurately reflects services provided, and that the client's best interest drives collaborative decisions. The ethical framework supports collaboration while maintaining accountability.
Each professional should collect discipline-specific data during co-treatment sessions. The behavior analyst should collect data on behavioral targets including response rates, prompt levels, reinforcement schedules, and behavioral observations. The collaborating professional should collect data relevant to their discipline such as communication frequency, sensory regulation indicators, or motor performance measures. Additionally, the team should track cross-disciplinary outcome measures that capture the integrated benefit of co-treatment, such as functional communication in natural contexts that combines both linguistic and behavioral components. Comparing progress rates during co-treatment versus individual therapy periods provides evidence for the effectiveness of the collaborative model.
Non-compliance with billing requirements for co-treatment can result in claim denials, recoupment of previously paid claims, audit flags that trigger broader reviews of the organization's billing practices, and potentially sanctions from payers or regulatory agencies. In serious cases, billing non-compliance can be considered fraudulent, which carries legal consequences. Organizations should respond to identified non-compliance by immediately correcting billing practices, conducting a retrospective review to identify the scope of the issue, voluntarily reporting and repaying any overclaimed amounts, implementing corrective measures to prevent recurrence, and providing additional training to affected staff. Proactive compliance monitoring is far less costly than responding to compliance failures.
The ABA Clubhouse has 60+ on-demand CEUs including ethics, supervision, and clinical topics like this one. Plus a new live CEU every Wednesday.
Ready to go deeper? This course covers this topic with structured learning objectives and CEU credit.
Ethical Implications of the Effective Use of an ABA Cotreat Model — Stephanie Nostin · 1 BACB Ethics CEUs · $16
Take This Course →1 BACB Ethics CEUs · $16 · BehaviorLive
Research-backed educational guide with practice recommendations
Side-by-side comparison with clinical decision framework
All behavior-analytic intervention is individualized. The information on this page is for educational purposes and does not constitute clinical advice. Treatment decisions should be informed by the best available published research, individualized assessment, and obtained with the informed consent of the client or their legal guardian. Behavior analysts are responsible for practicing within the boundaries of their competence and adhering to the BACB Ethics Code for Behavior Analysts.